The purchase of psychedelics drugmaker AtaiBeckley by the world's biggest pharmaceutical company comes as more clinical data on the efficacy of such compounds is emerging. Analysts say the deal will smooth the way for others in the psychedelics space.
Attorneys putting together big provider transactions today say they see a growing need for what they call a producer approach to their practice, in which they oversee law, finance, public messaging and internal coordination in tandem.
Despite a short week, healthcare dealmakers were busy at work, as Law360 counted at least four billion-dollar transactions involving names like BridgeBio and AstraZeneca. Here's a look at those deals and others.
Previous
Next
The purchase of psychedelics drugmaker AtaiBeckley by the world's biggest pharmaceutical company comes as more clinical data on the efficacy of such compounds is emerging. Analysts say the deal will smooth the way for others in the psychedelics space.
Attorneys putting together big provider transactions today say they see a growing need for what they call a producer approach to their practice, in which they oversee law, finance, public messaging and internal coordination in tandem.
Despite a short week, healthcare dealmakers were busy at work, as Law360 counted at least four billion-dollar transactions involving names like BridgeBio and AstraZeneca. Here's a look at those deals and others.
-
July 22, 2026
Fannie Mae has voluntarily dropped the remaining claims in its lawsuit accusing borrower Affinity Living Communities of defaulting on $28.3 million worth of loans from the government-backed lender, telling the court the appointed receivership had achieved its purpose.
-
July 22, 2026
Boston Scientific and Stryker Corp. have reached a settlement to resolve a case in New Jersey federal court over Stryker's alleged efforts to create a back pain device that infringed a Boston Scientific patent.
-
July 22, 2026
Safety-net healthcare providers urged the U.S. Supreme Court not to take on the revival of their proposed antitrust class action against Sanofi-Aventis, Eli Lilly, Novo Nordisk and AstraZeneca, arguing Wednesday that the Second Circuit's decision was based on neither mere trade group lobbying nor any kind of price-fixing.
-
July 22, 2026
Autonomous revenue cycle management platform Candid Health, advised by Lowenstein Sandler LLP, on Wednesday revealed that it raised $120 million in its latest funding round, marking a three-times increase in valuation over the San Francisco-based company's previous funding round in February 2025.
-
July 22, 2026
The Federal Circuit on Wednesday said it won't rethink a panel's decision invalidating patent claims covering parts used to make expandable implant devices in spinal fusion surgeries that were the basis of a $9.5 million jury verdict against Life Spine Inc.
-
July 21, 2026
Payors UnitedHealth and Elevance and pharma giant Johnson & Johnson all raised their 2026 guidance after positive second quarters. Law360 has what you need to know from earnings this week.
-
July 21, 2026
The Federal Circuit's holding that a Pfizer unit's cancer treatment patents are invalid highlights the risk of including dosages in patents without sufficient proof that those dosages work, attorneys say.
-
July 17, 2026
In this week's Taxation With Representation, Uber Technologies Inc. buys food delivery company Delivery Hero SE, engineering group ABB Ltd. acquires flow technology company Rotork PLC, and Eli Lilly and Co. buys drug developer AtaiBeckley Inc.
-
July 14, 2026
Goodwin Procter LLP announced on Tuesday that it had hired a veteran life sciences attorney to co-chair its new San Diego office, which is slated to open later this summer.
-
July 14, 2026
Artificial intelligence-based drug discovery company Chai Discovery on Tuesday revealed that it reached a $3.8 billion valuation after closing its latest funding round with $400 million in tow.
-
July 14, 2026
An attorney with nearly 25 years of experience in commercial and antitrust litigation has moved his practice to BakerHostetler's Philadelphia office after five years with Holland & Knight LLP.
-
July 13, 2026
California-based Edwards Lifesciences and Singapore's Genesis Medtech agreed to pay a combined $12 million to settle claims from the Federal Trade Commission that Edwards attempted to evade the Hart-Scott-Rodino notification and waiting period when it acquired medical device maker JC Medical from Genesis in 2024.
-
July 10, 2026
In this week's Taxation With Representation, Solstice Advanced Materials Inc. acquires specialty chemicals technology company Element Solutions Inc., Vertex Pharmaceuticals Inc. buys Crinetics Pharmaceuticals Inc., and Lockheed Martin acquires naval defense company Ultra Maritime.
-
July 09, 2026
Regeneron has told a Delaware federal judge there is new reason to preserve its $407 million win against Amgen over cholesterol drug bundling after a California federal judge found in an analogous case that the plaintiff need not prove the defendant had monopoly power over every item in a bundle.
-
July 08, 2026
A New Jersey federal judge has refused to let generic-drug company Tris Pharma Inc. escape a suit claiming its attempt to sell a competing version of Jazz Pharmaceuticals' narcolepsy drug Xyrem infringes a series of patents.
-
July 08, 2026
The U.S. Securities and Exchange Commission on Wednesday accused a former AstraZeneca Pharmaceuticals LP employee of using nonpublic information to trade ahead of the company's $1.1 billion acquisition of vaccine design company Icosavax Inc., yielding approximately $10,000 in illicit gains.
-
July 08, 2026
Handa Pharmaceuticals and Intas Pharmaceuticals are wrongly trying to bring to market drugs that would compete with Exelixis Inc.'s blockbuster cancer pill Cabometyx before patents on the medication expire, according to a new lawsuit in Delaware federal court.
-
July 08, 2026
The U.S. Supreme Court clarified the pleading standard for induced infringement of skinny labels, and the Federal Circuit opened the door to increased damages for patent owners. Here's what you need to know about these patent cases and other major decisions from the beginning of 2026.
-
July 07, 2026
A Texas federal jury has found that claims in four patents Invisalign maker Align Technology Inc. asserted against orthodontics company ClearCorrect were invalid, but the jurors also rejected ClearCorrect's antitrust claims against Align.
-
July 07, 2026
The Federal Circuit on Tuesday said it won't bring back claims in a pair of dental arch image analysis patents their owner accused Invisalign maker Align Technology Inc. of infringing, backing a lower court's finding that they were invalid.
-
July 06, 2026
Analytics company Clarivate PLC on Monday announced that it has agreed to sell its Life Sciences & Healthcare segment to investment firm Altaris LLC in a $600 million deal built by three law firms.
-
July 06, 2026
Summer is heating up in North Carolina Business Court with a slew of recent rulings, including one greenlighting a data breach class action brought by current and former workers who allege Charlotte-based Bojangles failed to guard their personal information from hackers.
-
July 06, 2026
Following several U.S. Supreme Court terms teeming with reversals and rebukes of lower appeals courts, the justices this term found fault less often with rulings by circuit judges, who are likely becoming better attuned to the conservative supermajority, attorneys say.
-
July 06, 2026
U.S. Supreme Court justices forged unusual alliances when they ruled a federal statute preempts claims Monsanto failed to warn consumers its Roundup weed killer may cause cancer. Oral arguments provided insights on the 7-2 outcome, highlighting issues the jurists were grappling with and showcasing rationales that found their way into the opinion.
-
July 06, 2026
When one of the U.S. Supreme Court's most talkative members suddenly struggled to speak, the atmosphere at oral arguments grew increasingly anxious — until the justice deadpanned that it was an advocate's golden opportunity to avoid a grilling.